Cargando…
Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review
RATIONALE: Case reports concerning the value of dopamine agonists in the treatment of patients with thyrotropin-secreting pituitary adenoma (TSHoma) are limited. Herein, we present a rare case of octreotide-insensitive TSHoma responding to bromocriptine therapy. PATIENT CONCERNS: A 45-year-old Chine...
Autores principales: | Yang, Chengxian, Wu, Huanwen, Wang, Jing, Hu, Mingming, Xing, Xiaoping, Bao, Xinjie, Wang, Renzhi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6393027/ https://www.ncbi.nlm.nih.gov/pubmed/28885368 http://dx.doi.org/10.1097/MD.0000000000008017 |
Ejemplares similares
-
Successful management of octreotide-insensitive thyrotropin-secreting pituitary adenoma with bromocriptine and surgery: A case report and literature review: Erratum
Publicado: (2017) -
Short-term Preoperative Octreotide for Thyrotropin-secreting Pituitary Adenoma
por: Fang, Hong-Juan, et al.
Publicado: (2017) -
Role of matrix Metalloproteinases in pituitary adenoma invasion
por: Yang, Chengxian, et al.
Publicado: (2018) -
Genetic and Epigenetic Causes of Pituitary Adenomas
por: Chang, Mengqi, et al.
Publicado: (2021) -
Thyrotropin-Secreting Pituitary Adenoma Successfully Treated With Cabergoline
por: Saand, Aisha R, et al.
Publicado: (2021)